Acute Liver Injury in Patients Hospitalized with COVID-19.

Lindsay A SobotkaJames EstebanMichael L VolkB Joseph ElmunzerDon C Rockeynull null

Published in: Digestive diseases and sciences (2021)

Transaminase elevation is common in hospitalized patients with COVID-19. Severe ALI is rare, and ALF may not be a complication of COVID-19. Extreme elevations in liver enzymes appear to be associated with mortality and longer LOS due to more severe systemic disease rather than SARS-CoV-2-related hepatitis.

Keyphrases

drug induced
liver injury
sars cov
coronavirus disease
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
newly diagnosed
chronic kidney disease
early onset
cardiovascular events
peritoneal dialysis
climate change
intensive care unit